UPC Analytics
DEEN
Übersicht · Eingereicht: 19. Dez. 2025

UPC_CoA_930/2025

FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

BerufungenHauptberufungCourt of AppealAppealCase Closed
Parteien

Kläger

  • Insulet Corporation
Vertreter: Marc Grunwald (Peterreins Schley)

Beklagte

  • EOFLOW Co., Ltd.
Vertreter: Mirko Weinert (Hoyng ROKH Monegier)
Richter
  • Rian Kalden
  • Patricia Rombach
  • Ingeborg Simonsson
  • Udo Matter
  • Steven Kitchen
Patente
  • EP4201327
  • EP 4 201 327
CPC-Codes: A61M5/1723, A61M5/1452, A61M5/158, A61B5/14865, A61M5/14244, F04B9/02, A61B5/14532, A61M2230/201, A61M2005/14506, A61M5/14248, B65D83/761, A61M5/3291

Sektor: Packaging & Conveying

Ausgang
Abgewiesen
Eingereicht: 19. Dez. 2025
Erste Entscheidung: 29. Jan. 2026
Letzte Entscheidung: 18. März 2026
Sprache: English

The Court of Appeal dismissed EOFlow's appeal against the Milan Central Division's order denying EOFlow's request under R. 262.2 RoP to keep certain information confidential. The Court held that information disclosed to the opposing party without an order under R. 262A RoP or other restriction loses its character as a trade secret. A R. 262.2 RoP request does not automatically protect information from disclosure by the other party. Information relating to a settlement agreement was also no longer confidential because its substance had already been stated in the published court order.

Im UPC-Register öffnen